Tolbutamide-d9
Tolbutamide-d9 Basic information
- Product Name:
- Tolbutamide-d9
- Synonyms:
-
- 1-(Butyl-3-(p-tolyl- sulfonyl)urea-d9
- 3-(p-Tolyl-4-sulfonyl)-1-butylurea-d9
- Artosin-d9
- Artozin-d9
- Mobenol-d9
- N-[(ButylaMino-d9)carbonyl]-4-MethylbenzenesulfonaMide
- N-Butyl-N'-(4-Methylphenylsulfonyl)urea-d9
- Tolylsulfonylbutylurea-d9
- CAS:
- 1219794-57-6
- MF:
- C12H18N2O3S
- MW:
- 270.35
- Product Categories:
-
- Aromatics
- Intermediates & Fine Chemicals
- Isotope Labelled Compounds
- Pharmaceuticals
- Sulfur & Selenium Compounds
- Mol File:
- 1219794-57-6.mol
Tolbutamide-d9 Chemical Properties
- Melting point:
- 108-111°C
- storage temp.
- Refrigerator
- solubility
- DMF: 30 mg/ml,DMSO: 30 mg/ml,Ethanol: 30 mg/ml,Ethanol:PBS (pH 7.2) (1:1): 0.14 mg/ml
- form
- A solid
- color
- White to off-white
Tolbutamide-d9 Usage And Synthesis
Description
Tolbutamide-d9 is intended for use as an internal standard for the quantification of tolbutamide by GC- or LC-MS. Tolbutamide is an inhibitor of sulfonylurea receptor 1 (SUR1) linked to ATP-sensitive potassium channel Kir6.2 (IC50 = 4.9 μM). It is selective for SUR1/Kir6.2 over SUR2A/Kir6.2 and SUR2B/Kir6.2 channels (IC50s = 85 and 88 μM, respectively). Tolbutamide increases glucose-induced insulin secretion and calcium influx in isolated mouse pancreatic islets. In vivo, tolbutamide (80 mg/kg) reduces blood glucose levels in a mouse model of diabetes induced by streptozotocin (STZ; ). Formulations containing tolbutamide have been used in the treatment of type 2 diabetes.
Chemical Properties
White Solid
Uses
Labelled Tolbutamide (T535150). An antidiabetic, used as a hypoglycemic agent in veterinary medicine.
References
[1] PETER PROKS. Sulfonylurea stimulation of insulin secretion.[J]. Diabetes, 2002, 51 Suppl 3: S368-76. DOI: 10.2337/diabetes.51.2007.s368
[2] NOBUYOSHI ISHIYAMA Jean C H Magalie A Ravier. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets.[J]. American journal of physiology. Endocrinology and metabolism, 2006, 290 3: E540-9. DOI: 10.1152/ajpendo.00032.2005
[3] CLAUS RERUP Finn T. Streptozotocin- and alloxan-diabetes in mice[J]. European journal of pharmacology, 1969, 7 1: Pages 89-96. DOI: 10.1016/0014-2999(69)90169-1
Tolbutamide-d9Supplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 022-6537-8550 15522853686
- sales@altasci.com.cn
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 025-84622273 17361806303
- kexin.zhou@haolvbiotech.com